Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
/	O
Amiodarone	O
Hcl	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Fatigue,	O
Dyspnea,	O
Fever	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
thoracentesis	O
___	O
bronchoscopy	O
___	O
History	O
of	O
Present	O
Illness:	O
The	O
patient	O
is	O
a	O
___	O
year	O
old	O
male	O
with	O
medical	O
history	O
pertinent	O
for	O
CAD,	O
Chronic	O
Systolic	O
CHF,	O
CKD	O
and	O
DM	O
who	O
was	O
recently	O
hospitalized	O
at	O
___	O
from	O
___	O
to	O
___	O
for	O
management	O
at	O
that	O
time	O
of	O
CAP	B-Lower_respiratory_tract_infection
vs.	O
aspiration	O
PNA	B-Lower_respiratory_tract_infection
with	O
initial	O
CXR	O
revealing	O
for	O
left	O
lower	O
lobe	O
infiltrate,	O
CT	O
abdomen	O
revealing	O
evidence	O
of	O
bibasilar	O
consolidations.	O
The	O
patient	O
was	O
treated	O
with	O
Levofloxacin	O
with	O
additional	O
concern	O
for	O
aspiration	O
given	O
a	O
reported	O
witnessed	O
aspiration	O
event.	O
The	O
patient	O
was	O
seen	O
by	O
speech	O
and	O
swallow	O
and	O
passed	O
although	O
video	O
study	O
revealed	O
mild	O
oropharyngeal	O
dysphagia	O
for	O
which	O
aspiration	O
precautions	O
was	O
recommended,	O
regular	O
consistency	O
diet.	O
The	O
patient	O
had	O
sputum	O
cultures	O
with	O
gross	O
contamination,	O
Urine	O
legionella	O
negative.	O
The	O
patient's	O
breathing	O
and	O
coughing	O
were	O
noted	O
to	O
improve	O
and	O
the	O
patient	O
was	O
weaned	O
from	O
oxygen.	O
The	O
patient's	O
course	O
was	O
otherwise	O
complicated	O
by	O
acute	O
renal	O
failure	O
which	O
resolved	O
with	O
holding	O
ACE	O
and	O
diuretics	O
as	O
well	O
as	O
IVF	O
resuscitation.	O
The	O
patient	O
was	O
noted	O
to	O
have	O
a	O
Troponin	O
0.1	O
x	O
3	O
thought	O
to	O
reflect	O
demand	O
___	O
setting	O
of	O
illness	O
and	O
renal	O
insufficiency.	O
The	O
patient	O
had	O
a	O
few	O
bouts	O
of	O
loose	O
stool,	O
D.	O
Ciff	O
testing	O
negative.	O
A	O
CT	O
Abd/Pelvis	O
revealed	O
no	O
acute	O
intraabominal	O
process	O
at	O
that	O
time.	O
The	O
patient	O
had	O
a	O
positive	O
UA	O
but	O
urine	O
culture	O
without	O
growth.	O
The	O
patient's	O
course	O
was	O
additioanlly	O
complicated	O
by	O
a	O
traumatic	O
foley	O
placement	O
with	O
hematuria	O
requiring	O
CBI	O
which	O
has	O
been	O
ongoing	O
since	O
the	O
time	O
of	O
discharge.	O
Since	O
discharge	O
to	O
the	O
___	O
step-down	O
unit,	O
the	O
patient	O
reports	O
he	O
was	O
feeling	O
generally	O
the	O
same	O
until	O
this	O
a.m.	O
He	O
has	O
had	O
stable	O
shortness	O
of	O
breath	O
without	O
obvious	O
worsening	O
by	O
him	O
although	O
his	O
accompanying	O
famil	O
members	O
believe	O
this	O
has	O
become	O
worse.	O
The	O
patient	O
reports	O
his	O
main	O
complaint	O
is	O
that	O
of	O
tremors	O
this	O
morning	O
and	O
a	O
sensation	O
of	O
weakness.	O
The	O
patient	O
and	O
his	O
family	O
report	O
that	O
the	O
patient	O
at	O
times	O
today	O
has	O
appeared	O
unwell	O
and	O
has	O
had	O
hand	O
and	O
leg	O
tremoring	O
although	O
nothing	O
that	O
sounds	O
concerning	O
for	O
seizure	B-Seizures
activity,	O
no	O
dysarthria,	O
limb	O
weakness	O
or	O
other	O
focal	O
neurologic	O
signs.	O
The	O
patient	O
was	O
noted	O
to	O
have	O
a	O
fever	O
to	O
101.0	O
at	O
his	O
rehab	O
this	O
a.m.	O
and	O
the	O
patient	O
and	O
his	O
family	O
report	O
he	O
has	O
been	O
experiencing	O
chills	O
and	O
rigoring	O
over	O
the	O
last	O
day.	O
As	O
above,	O
the	O
patient	O
reports	O
he	O
feels	O
his	O
breathing	O
remains	O
labored	O
but	O
not	O
clearly	O
worse	O
than	O
prior,	O
he	O
continues	O
to	O
experience	O
a	O
non-productive	O
cough.	O
The	O
patient	O
has	O
been	O
receiving	O
CBI	O
with	O
clear	O
urine	O
for	O
a	O
few	O
days,	O
he	O
denies	O
significant	O
dysuria.	O
The	O
patient	O
otherwise	O
denies	O
abdominal	O
pain,	O
does	O
report	O
nausea	O
but	O
no	O
vomiting,	O
no	O
diarrhea.	O
Review	O
of	O
systems	O
otherwise	O
pertinent	O
for	O
left	O
shoulder	O
pain	O
which	O
is	O
new	O
over	O
last	O
___	O
days.	O
.	O
ED	O
Course:	O
97.9,	O
148/116,	O
80,	O
18,	O
94%	O
RA.	O
While	O
___	O
the	O
ED	O
the	O
patient	O
dropped	O
his	O
blood	O
pressure	O
to	O
76/30,	O
improved	O
to	O
120/40	O
after	O
500cc	O
bolus	O
x	O
2	O
___	O
ED.	O
The	O
patient	O
had	O
labs	O
notable	O
for	O
WBC	O
14.9,	O
lactate	O
1.6,	O
proBNP	O
11,771,	O
Trop	O
.05	O
and	O
UA	O
with	O
>50	O
RBC,	O
___	O
WBC	O
with	O
few	O
bacteria.	O
The	O
patient	O
had	O
a	O
portable	O
CXR	O
performed	O
revealing	O
left	O
lower	O
lobe	O
collapse	O
(?	O
mucus	O
plug	O
versus	O
central	O
obstructing	O
lesion)	O
without	O
ability	O
to	O
rule	O
out	O
superimposed	O
PNA	B-Lower_respiratory_tract_infection
as	O
well	O
as	O
interval	O
development	O
of	O
a	O
moderate	O
sized	O
left	O
pleural	O
effusion	O
since	O
___.	O
The	O
patient	O
received	O
Vancomycin,	O
Ceftaz,	O
and	O
Levofloxacin	O
and	O
is	O
now	O
admitted	O
to	O
the	O
medical	O
service	O
for	O
ongoing	O
care.	O
Past	O
Medical	O
History:	O
#.	O
CAD	O
-	O
s/p	O
3V-CABG	O
and	O
stenting	O
-	O
MI	O
___	O
years	O
ago	O
#.	O
Congestive	O
Heart	O
Failure	O
-	O
EF	O
40%	O
on	O
Echo	O
___	O
-	O
Severe	O
Miral	O
Regurgitation	O
and	O
Tricuspid	O
Regurgitation	O
#.	O
Atrial	O
fibrillation	O
-	O
s/p	O
BiV	O
pacemaker	O
-	O
___	O
-	O
off	O
Coumadin	O
due	O
to	O
GI	B-Upper_gastrointestinal_haemorrhage
bleed	B-Upper_gastrointestinal_haemorrhage
history	O
#.	O
Type	O
II	O
Diabetes	O
Mellitus	O
#.	O
Chronic	O
Kidney	O
Disease	O
#.	O
Hypertension	O
#.	O
GIB	B-Upper_gastrointestinal_haemorrhage
-	O
has	O
required	O
transfusions,	O
source	O
unidentified	O
after	O
capsule	O
study	O
#.	O
History	O
of	O
Colon	O
Cancer	O
___	O
-	O
s/p	O
colectomy	O
and	O
ileoanal	O
anastomosis,	O
7	O
wks	O
radiation,	O
complication	O
of	O
radiation	O
proctitis	O
#.	O
BPH	O
Social	O
History:	O
___	O
Family	O
History:	O
There	O
is	O
no	O
family	O
history	O
of	O
premature	O
coronary	O
artery	O
disease	O
or	O
sudden	O
death.	O
Brother	O
died	O
of	O
MI	O
at	O
___,	O
sister	O
died	O
of	O
MI	O
at	O
___.	O
Mother	O
died	O
at	O
___	O
from	O
complications	O
from	O
PNA.	B-Lower_respiratory_tract_infection
Father	O
died	O
at	O
___	O
during	O
cholecystectomy.	O
Physical	O
Exam:	O
Vitals:	O
97.5,	O
100/60,	O
76,	O
20,	O
100%	O
3L	O
NC	O
->	O
97%	O
2L	O
NC	O
General:	O
Patient	O
is	O
an	O
elderly	O
male,	O
appears	O
frail	B-Frailty
currently,	O
fatigued.	O
Patient	O
is	O
awake,	O
alert,	O
answers	O
questions	O
appropriately	O
HEENT:	O
NCAT,	O
EOMI,	O
sclera	O
anicteric,	O
conjunctiva	O
WNL	O
OP:	O
MMM	O
Neck:	O
Thin,	O
EJ	O
distended	O
to	O
8cm	O
although	O
IJ	O
not	O
well	O
visualized,	O
appears	O
to	O
be	O
fairly	O
flat	O
Chest:	O
Generally	O
CTA	O
anterior,	O
posterior	O
exam	O
with	O
decreased	O
breath	O
sounds	O
at	O
left	O
base.	O
No	O
definite	O
rales,	O
rhonchi,	O
wheezing	O
Cor:	O
RRR,	O
III/VI	O
systolic	O
murmur	O
loudest	O
at	O
LLSB	O
Abdomen:	O
mildly	O
distended,	O
Hyperactive	O
bowel	O
sounds,	O
tympanitic	O
to	O
percussion.	O
Soft	O
and	O
non-tender	O
throughout	O
Ext:	O
trace	O
___	O
edema.	O
Left	O
shoulder	O
not	O
warm,	O
no	O
erythema,	O
no	O
obvious	O
effusion,	O
no	O
pain	O
with	O
passive	O
motion	O
of	O
shoulder	O
Skin/Nails:	O
Multiple	O
eccymosis,	O
no	O
rash	O
Neuro:	O
Grossly	O
intact,	O
patient	O
with	O
occasional	O
tremor	O
vs.	O
small	O
rigor	O
Pertinent	O
Results:	O
___	O
08:55PM	O
CK(CPK)-28*	O
___	O
08:55PM	O
CK-MB-2	O
cTropnT-0.04*	O
___	O
02:05PM	O
URINE	O
HOURS-RANDOM	O
___	O
02:05PM	O
URINE	O
UHOLD-HOLD	O
___	O
02:05PM	O
URINE	O
COLOR-Yellow	O
APPEAR-Hazy	O
SP	O
___	O
___	O
02:05PM	O
URINE	O
BLOOD-LG	O
NITRITE-NEG	O
PROTEIN-NEG	O
GLUCOSE-NEG	O
KETONE-NEG	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-5.0	O
LEUK-SM	O
___	O
02:00PM	O
GLUCOSE-127*	O
UREA	O
N-43*	O
CREAT-1.7*	O
SODIUM-137	O
POTASSIUM-5.1	O
CHLORIDE-99	O
TOTAL	O
CO2-32	O
ANION	O
GAP-11	O
___	O
02:00PM	O
estGFR-Using	O
this	O
___	O
02:00PM	O
CK(CPK)-33*	O
___	O
02:00PM	O
CK-MB-2	O
cTropnT-0.05*	O
___	O
___	O
02:00PM	O
CALCIUM-8.4	O
PHOSPHATE-3.6	O
MAGNESIUM-2.1	O
___	O
02:00PM	O
DIGOXIN-0.3*	O
___	O
02:00PM	O
LACTATE-1.6	O
___	O
02:00PM	O
WBC-14.9*#	O
RBC-3.20*	O
HGB-10.0*	O
HCT-30.8*	O
MCV-96	O
MCH-31.2	O
MCHC-32.4	O
RDW-18.0*	O
___	O
02:00PM	O
NEUTS-90.9*	O
LYMPHS-5.5*	O
MONOS-3.0	O
EOS-0.4	O
BASOS-0.1	O
___	O
02:00PM	O
PLT	O
COUNT-567*#	O
___	O
02:00PM	O
___	O
PTT-33.5	O
___	O
.	O
CT	O
lungs:Final	O
Report	O
HISTORY:	O
___	O
male	O
with	O
recent	O
left	O
lower	O
lobe	O
pneumonia.	B-Lower_respiratory_tract_infection
Now	O
with	O
concern	O
for	O
left	O
lower	O
lobe	O
collapse	O
and	O
underlying	O
obstructing	O
mass	O
lesion.	O
COMPARISON:	O
Chest	O
radiographs,	O
___,	O
and	O
___.	O
TECHNIQUE:	O
MDCT	O
axial	O
images	O
of	O
the	O
chest	O
obtained	O
after	O
Optiray	O
IV	O
contrast	O
with	O
multiplanar	O
reformats.	O
CT	O
OF	O
THE	O
CHEST	O
WITH	O
IV	O
CONTRAST:	O
Bilateral	O
pleural	O
effusions	O
are	O
large	O
on	O
the	O
left	O
and	O
small	O
on	O
the	O
right.	O
There	O
is	O
complete	O
collapse	O
of	O
the	O
left	O
lower	O
lobe.	O
The	O
left	O
lower	O
lobe	O
bronchus	O
is	O
not	O
aerated	O
and	O
appears	O
to	O
be	O
impacted	O
with	O
secretions.	O
No	O
underlying	O
obstructing	O
mass	O
lesion	O
is	O
seen.	O
There	O
is	O
dependent	O
atelectasis	O
of	O
the	O
right	O
lower	O
lobe	O
and	O
lingula.	O
A	O
few	O
small	O
calcified	O
and	O
noncalcified	O
pulmonary	O
nodules	O
measure	O
less	O
than	O
4	O
mm	O
___	O
size.	O
There	O
is	O
no	O
focal	O
airspace	O
consolidation	O
or	O
pneumothorax.	O
The	O
patient	O
is	O
status	O
post	O
sternotomy	O
and	O
CABG.	O
There	O
is	O
extensive	O
severe	O
calcification	O
of	O
all	O
coronary	O
arteries.	O
There	O
are	O
no	O
pathologically	O
enlarged	O
mediastinal,	O
axillary,	O
or	O
hilar	O
lymph	O
nodes.	O
There	O
is	O
evidence	O
of	O
right	O
heart	O
dysfunction	O
with	O
large	O
caliber	O
IVC	O
and	O
reflux	O
of	O
contrast	O
into	O
the	O
IVC	O
and	O
hepatic	O
veins.	O
Limited	O
evaluation	O
of	O
the	O
upper	O
abdomen	O
shows	O
atherosclerotic	O
calcifications	O
of	O
the	O
aorta,	O
which	O
involve	O
the	O
ostia	O
of	O
the	O
celiac	O
trunk,	O
SMA,	O
and	O
renal	O
arteries.	O
Several	O
small	O
dependent	O
gallstones	O
are	O
noted.	O
No	O
concerning	O
lytic	O
or	O
blastic	O
osseous	O
lesions	O
are	O
detected.	O
IMPRESSION:	O
1.	O
Collapse	O
of	O
the	O
left	O
lower	O
lobe	O
appears	O
to	O
be	O
due	O
to	O
mucoid	O
impaction	O
for	O
which	O
bronchoscopy	O
may	O
be	O
helpful.	O
No	O
evidence	O
of	O
obstructing	O
mass.	O
2.	O
Bilateral	O
pleural	O
effusions,	O
large	O
on	O
the	O
left	O
and	O
small	O
on	O
the	O
right.	O
3.	O
Atherosclerosis	O
including	O
severe	O
native	O
coronary	O
artery	O
calcification.	O
4.	O
Cholelithiasis.	O
.	O
TTE	O
:The	O
left	O
atrium	O
is	O
markedly	O
dilated.	O
There	O
is	O
mild	O
symmetric	O
left	O
ventricular	O
hypertrophy.	O
The	O
left	O
ventricular	O
cavity	O
is	O
moderately	O
dilated.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
moderately	O
depressed	O
(LVEF=	O
___	O
%)	O
secondary	O
to	O
akinesis	O
of	O
the	O
inferior	O
and	O
posterior	O
walls,	O
and	O
severe	O
hypokinesis-to-akinesis	O
of	O
the	O
lateral	O
wall.	O
[Intrinsic	O
left	O
ventricular	O
systolic	O
function	O
is	O
likely	O
more	O
depressed	O
given	O
the	O
severity	O
of	O
valvular	O
regurgitation.]	O
There	O
is	O
no	O
ventricular	O
septal	O
defect.	O
The	O
right	O
ventricular	O
free	O
wall	O
is	O
hypertrophied.	O
The	O
right	O
ventricular	O
cavity	O
is	O
dilated	O
with	O
depressed	O
free	O
wall	O
contractility.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened.	O
There	O
is	O
a	O
minimally	O
increased	O
gradient	O
consistent	O
with	O
minimal	O
aortic	O
valve	O
stenosis.	O
Mild	O
(1+)	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse;	O
the	O
anterior	O
leaflet	O
is	O
tethered.	O
An	O
eccentric,	O
anteriorly	O
directed	O
jet	O
of	O
severe	O
(4+)	O
mitral	O
regurgitation	O
is	O
seen.	O
The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
Moderate	O
to	O
severe	O
[3+]	O
tricuspid	O
regurgitation	O
is	O
seen.	O
There	O
is	O
severe	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
The	O
main	O
pulmonary	O
artery	O
is	O
dilated.	O
The	O
branch	O
pulmonary	O
arteries	O
are	O
dilated.	O
There	O
is	O
no	O
pericardial	O
effusion.	O
.	O
CXR	O
___	O
post-bronch	O
(prelimary	O
report):	O
slight	O
improvement	O
aeration	O
right	O
base.	O
Persistent	O
opacity	O
left	O
base	O
combination	O
of	O
effusion	O
of	O
atelectasis/consolidation.	O
.	O
___	O
12:42	O
pm	O
STOOL	O
CONSISTENCY:	O
NOT	O
APPLICABLE	O
Source:	O
Stool.	O
**FINAL	O
REPORT	O
___	O
CLOSTRIDIUM	O
DIFFICILE	O
TOXIN	O
A	O
&	O
B	O
TEST	O
(Final	O
___:	O
Feces	O
negative	O
for	O
C.difficile	O
toxin	O
A	O
&	O
B	O
by	O
EIA.	O
(Reference	O
Range-Negative).	O
___	O
5:26	O
pm	O
PLEURAL	O
FLUID	O
GRAM	O
STAIN	O
(Final	O
___:	O
4+	O
(>10	O
per	O
1000X	O
FIELD):	O
POLYMORPHONUCLEAR	O
LEUKOCYTES.	O
NO	O
MICROORGANISMS	O
SEEN.	O
This	O
is	O
a	O
concentrated	O
smear	O
made	O
by	O
cytospin	O
method,	O
please	O
refer	O
to	O
hematology	O
for	O
a	O
quantitative	O
white	O
blood	O
cell	O
count..	O
FLUID	O
CULTURE	O
(Preliminary):	O
NO	O
GROWTH.	O
ANAEROBIC	O
CULTURE	O
(Preliminary):	O
NO	O
GROWTH.	O
___	O
8:52	O
am	O
BRONCHOALVEOLAR	O
LAVAGE	O
Site:	O
LOWER	O
LOBE	O
LT.	O
LOWER	O
LOBE.	O
GRAM	O
STAIN	O
(Final	O
___:	O
NO	O
POLYMORPHONUCLEAR	O
LEUKOCYTES	O
SEEN.	O
1+	O
(<1	O
per	O
1000X	O
FIELD):	O
GRAM	O
POSITIVE	O
COCCI.	O
___	O
PAIRS	O
AND	O
CLUSTERS.	O
RESPIRATORY	O
CULTURE	O
(Preliminary):	O
FUNGAL	O
CULTURE	O
(Preliminary):	O
ACID	O
FAST	O
SMEAR	O
(Preliminary):	O
ACID	O
FAST	O
CULTURE	O
(Preliminary):	O
___	O
2:05	O
pm	O
URINE	O
Site:	O
CATHETER	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
STAPHYLOCOCCUS,	O
COAGULASE	O
NEGATIVE.	O
>100,000	O
ORGANISMS/ML..	O
COAG	O
NEG	O
STAPH	O
does	O
NOT	O
require	O
contact	O
precautions,	O
regardless	O
of	O
resistance	O
Oxacillin	O
RESISTANT	O
Staphylococci	O
MUST	O
be	O
reported	O
as	O
also	O
RESISTANT	O
to	O
other	O
penicillins,	O
cephalosporins,	O
carbacephems,	O
carbapenems,	O
and	O
beta-lactamase	O
inhibitor	O
combinations.	O
SENSITIVITIES:	O
MIC	O
expressed	O
___	O
MCG/ML	O
_________________________________________________________	O
STAPHYLOCOCCUS,	O
COAGULASE	O
NEGATIVE	O
|	O
GENTAMICIN------------	O
<=0.5	O
S	O
LEVOFLOXACIN----------	O
=>8	O
R	O
NITROFURANTOIN--------	O
<=16	O
S	O
OXACILLIN-------------	O
=>4	O
R	O
TETRACYCLINE----------	O
<=1	O
S	O
VANCOMYCIN------------	O
2	O
S	O
___	O
2:29	O
am	O
URINE	O
Source:	O
Catheter.	O
**FINAL	O
REPORT	O
___	O
URINE	O
CULTURE	O
(Final	O
___:	O
NO	O
GROWTH.	O
___	O
2:20	O
pm	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Pending):	O
Brief	O
Hospital	O
Course:	O
The	O
patient	O
is	O
a	O
___	O
year	O
old	O
male	O
with	O
medical	O
history	O
pertinent	O
for	O
CAD	O
s/p	O
CABG,	O
Chronic	O
Systolic	O
CHF	O
(EF	O
40%),	O
afib	O
s/p	O
PPM	O
not	O
on	O
coumadin	O
who	O
now	O
presented	O
with	O
symptoms	O
of	O
fatigue,	O
dyspnea	O
and	O
fever	O
at	O
___	O
after	O
recent	O
treatment	O
for	O
presumed	O
LLL	O
Aspiration	O
PNA.	B-Lower_respiratory_tract_infection
.	O
#.	O
Pneumonia,	B-Lower_respiratory_tract_infection
HCAP:	B-Lower_respiratory_tract_infection
The	O
patient	O
presented	O
from	O
___	O
with	O
report	O
of	O
fever	O
to	O
101,	O
increased	O
O2	O
requirement	O
and	O
R>L	O
effusion	O
___	O
distribution	O
where	O
patient	O
recently	O
had	O
a	O
known	O
pneumonia	B-Lower_respiratory_tract_infection
with	O
rise	O
___	O
leukocytosis.	O
Although	O
pleural	O
effusion	O
may	O
be	O
from	O
multiple	O
etiologies	O
(see	O
below),	O
given	O
fever	O
and	O
episode	O
of	O
hypotension	O
___	O
ED,	O
concern	O
was	O
for	O
evolution	O
of	O
PNA	B-Lower_respiratory_tract_infection
with	O
possible	O
parapneumonic	B-Lower_respiratory_tract_infection
effusion/empyema.	O
Coverage	O
was	O
broadened	O
for	O
HCAP	B-Lower_respiratory_tract_infection
given	O
recent	O
hospitalization	O
and	O
potential	O
evolution	O
despite	O
therapy	O
with	O
Quinolone/Flagyl	O
(since	O
___	O
with	O
Vanc/Ceftazidime	O
(___).	O
IP	O
was	O
consulted	O
and	O
performed	O
thoracentesis	O
on	O
___	O
with	O
1.2	O
L	O
of	O
serous	O
fluid	O
withdrawn.	O
This	O
fluid	O
was	O
consistent	O
with	O
a	O
transudate,	O
likely	O
from	O
pts	O
poor	O
cardiac	O
function/chronic	O
biventricular	O
CHF.	O
A	O
midline	O
was	O
placed	O
on	O
___	O
for	O
pt	O
to	O
complete	O
a	O
7	O
day	O
course	O
of	O
Vanc/Ceftazidime.	O
Of	O
note,	O
bronchoscopy	O
on	O
___	O
did	O
reveal	O
erythema	O
and	O
friability	O
of	O
the	O
LLL,	O
consistent	O
with	O
a	O
recent	O
infection.	O
.	O
#.	O
Pleural	O
Effusion:	O
Patient	O
has	O
a	O
known	O
history	O
of	O
systolic	O
CHF	O
with	O
a	O
few	O
hospitalizations	O
for	O
the	O
same	O
over	O
the	O
last	O
few	O
months.	O
BNP	O
was	O
elevated	O
to	O
___	O
although	O
likely	O
chronically	O
so,	O
clinically	O
volume	O
status	O
was	O
difficult	O
to	O
assess	O
definitively,	O
Pt	O
had	O
a	O
large	O
left	O
sided	O
pleural	O
effusion	O
and	O
small	O
right	O
sided	O
pleural	O
effusion.	O
He	O
did	O
not	O
have	O
noted	O
any	O
significant	O
pulmonary	O
vascular	O
congestion,	O
and	O
weight	O
was	O
145	O
lbs,	O
consistent	O
with	O
his	O
dry	O
weight.	O
IP	O
was	O
consulted	O
and	O
performed	O
thoracentesis	O
on	O
___	O
with	O
1.2	O
L	O
of	O
serous	O
fluid	O
withdrawn.	O
This	O
appeared	O
consistent	O
with	O
a	O
transudate.	O
Cytology	O
was	O
also	O
sent.	O
It	O
was	O
felt	O
the	O
pts	O
effusion	O
was	O
likely	O
due	O
to	O
CHF,	O
so	O
CHF	O
consultation	O
was	O
requested	O
as	O
per	O
below.	O
Pleural	O
fluid	O
cytology	O
was	O
negative	O
for	O
malignant	O
cells.	O
.	O
#.	O
Chronic	O
Systolic	O
CHF,	O
biventricular	O
heart	O
failure,	O
EF	O
40%:	O
___	O
___,	O
mild	O
symmetric	O
LVH,	O
severe	O
MR/TR.	O
Also	O
pt	O
had	O
borderline	O
RV	O
function.	O
Repeat	O
TTE	O
showed	O
EF30-40%,	O
severe	O
TR/MR,	O
and	O
severe	O
pulmonary	O
HTN.	O
CHF	O
team	O
was	O
consulted	O
(Dr.	O
___,	O
and	O
stated	O
that	O
pt	O
has	O
end	O
stage	O
heart	O
disease.	O
Goal	O
is	O
to	O
afterload	O
reduce	O
and	O
keep	O
SBP	O
___	O
___.	O
It	O
was	O
felt	O
his	O
pleural	O
effusions	O
are	O
likely	O
due	O
to	O
CHF	O
and	O
LV	O
failure/severe	O
MR.	O
___	O
was	O
restarted	O
on	O
his	O
carvedilol,	O
torsemide	O
(at	O
20	O
mg	O
daily,	O
titrated	O
up	O
to	O
20	O
mg	O
bid	O
prior	O
to	O
discharge),	O
and	O
lisinopril	O
at	O
2.5	O
mg	O
daily	O
(titrated	O
up	O
to	O
10	O
mg	O
daily	O
prior	O
to	O
discharge).	O
Given	O
digoxin	O
level	O
of	O
0.3,	O
his	O
digoxin	O
was	O
increased	O
to	O
daily.	O
His	O
digoxin	O
level	O
should	O
be	O
repeated	O
___	O
5	O
days.	O
His	O
lisinopril	O
and	O
torsemide	O
should	O
be	O
titrated	O
up	O
to	O
keep	O
creatinine	O
at	O
approx	O
2.0	O
and	O
SBP	O
___	O
___	O
(he	O
has	O
been	O
on	O
torsemide	O
40	O
mg	O
twice	O
daily	O
___	O
the	O
past).	O
Cr	O
was	O
1.5	O
prior	O
to	O
discharge.	O
Patient	O
does	O
not	O
clinically	O
appear	O
grossly	O
volume	O
overloaded	O
although	O
BNP	O
is	O
elevated.	O
Best	O
dry	O
weight	O
is	O
___	O
140s	O
up	O
to	O
150	O
per	O
OMR,	O
currently	O
pt	O
weighs	O
145	O
lbs.	O
Goal	O
per	O
cardiology	O
is	O
to	O
get	O
SBP	O
___	O
the	O
___,	O
and	O
allow	O
for	O
pt	O
dizziness/lightheadedness.	O
Per	O
cardiology,	O
pt	O
will	O
likely	O
need	O
to	O
be	O
mildly	O
lightheaded	O
with	O
his	O
blood	O
pressure	O
___	O
order	O
to	O
optimize	O
cardiac	O
function,	O
and	O
it	O
will	O
be	O
a	O
delicate	O
balance.	O
Pt	O
has	O
follow	O
up	O
with	O
Dr.	O
___	O
___	O
clinic	O
scheduled	O
for	O
next	O
month.	O
.	O
#	O
LLL	O
Lung	O
collapse:	O
Pt	O
had	O
LLL	O
collapse,	O
felt	O
to	O
be	O
due	O
to	O
either	O
mucoid	O
impaction	O
(noted	O
on	O
CT	O
scan)	O
vs.	O
the	O
pleural	O
effusion.	O
After	O
thoracentesis	O
there	O
was	O
not	O
much	O
expansion,	O
so	O
pt	O
was	O
taken	O
for	O
bronchoscopy	O
on	O
___.	O
This	O
revealed	O
R	O
mainstem,	O
RML,	O
RLL	O
white	O
secretions	O
(?barium	O
aspiration)	O
and	O
LLL	O
edematous	O
meucosa	O
with	O
friability	O
likely	O
due	O
to	O
pneumonia.	B-Lower_respiratory_tract_infection
This	O
did	O
not	O
result	O
___	O
any	O
lung	O
expansion	O
___	O
the	O
LLL	O
on	O
follow	O
up	O
CXR.	O
.	O
#.	O
Fever:	O
Patient	O
with	O
fever	O
to	O
101.0	O
reported	O
at	O
___	O
with	O
rise	O
___	O
leukocytosis	O
concerning	O
for	O
infectious	O
process	O
on	O
admission.	O
Afebrile	O
while	O
here.	O
UA	O
with	O
WBC	O
but	O
___	O
setting	O
of	O
>	O
50RBC.	O
Initial	O
urine	O
culture	O
here	O
grew	O
coag	O
neg.	O
staph,	O
but	O
on	O
the	O
following	O
day	O
was	O
negative.	O
Suspect	O
contamination/colonization	O
given	O
pt	O
has	O
had	O
a	O
foley	O
___.	O
Regardless,	O
pt	O
is	O
being	O
treated	O
with	O
Vancomycin	O
for	O
his	O
PNA.	B-Lower_respiratory_tract_infection
C	O
diff	O
was	O
negative.	O
Pts	O
pleural	O
effusion	O
was	O
not	O
consistent	O
empyema	O
and	O
culture	O
was	O
negative	O
for	O
infection.	O
He	O
will	O
be	O
treated	O
as	O
per	O
above	O
for	O
HCAP.	B-Lower_respiratory_tract_infection
.	O
#.	O
Hypotension:	O
Patient	O
with	O
hypotension	O
with	O
SBP	O
___	O
high	O
___	O
___	O
ED,	O
recovered	O
to	O
120	O
with	O
500cc	O
NS	O
bolus	O
x	O
2.	O
Unclear	O
etiology	O
for	O
this	O
drop	O
___	O
BP.	O
Lactate	O
reassuring	O
at	O
1.6.	O
Cardiac	O
enzymes	O
neg	O
x2.	O
Initially	O
held	O
lisinopril,	O
carvedilol,	O
and	O
torsemide,	O
but	O
then	O
resumed	O
them	O
with	O
goal	O
SBP	O
___	O
___	O
upon	O
discussion	O
with	O
CHF	O
team	O
(Dr.	O
___	O
as	O
per	O
above.	O
.	O
#.	O
CAD	O
s/p	O
bypass	O
graft:	O
Patient	O
with	O
history	O
of	O
known	O
CAD	O
s/p	O
CABG,	O
last	O
admission	O
Trop	O
mildly	O
elevated	O
at	O
.10	O
x	O
3	O
thought	O
secondary	O
to	O
demand.	O
CE	O
added	O
to	O
ER	O
admission	O
labs	O
revealing	O
Trop	O
.05	O
->	O
.04.	O
ASA	O
was	O
continued.	O
Initially	O
due	O
to	O
hypotensive	O
episode	O
pts	O
coreg	O
and	O
lisinopril	O
were	O
held,	O
but	O
these	O
were	O
restarted.	O
.	O
#.	O
Urinary	O
Retention/Hematuria:	O
Patient	O
had	O
a	O
traumatic	O
foley	O
placement	O
last	O
admission	O
with	O
urethral	O
injury	O
requiring	O
CBI	O
for	O
gross	O
hematuria.	O
Patient	O
had	O
clear	O
urine	O
here.	O
Plan	O
was	O
for	O
outpatient	O
follow	O
up	O
with	O
urology	O
on	O
___	O
to	O
have	O
foley	O
removed,	O
but	O
pt	O
was	O
inpatient.	O
While	O
here,	O
pts	O
foley	O
was	O
removed	O
and	O
pt	O
was	O
given	O
a	O
voiding	O
trial	O
on	O
___.	O
He	O
was	O
retaining	O
from	O
500-850	O
cc	O
___	O
his	O
bladder,	O
so	O
foley	O
was	O
replaced	O
again.	O
Would	O
repeat	O
voiding	O
trial	O
again	O
___	O
several	O
days.	O
Per	O
pt,	O
he	O
did	O
not	O
have	O
any	O
urinary	O
difficulty/BPH	O
symptoms	O
prior	O
to	O
his	O
last	O
admission	O
(with	O
traumatic	O
foley	O
placement).	O
.	O
#.	O
Diabetes	O
Mellitus	O
II	O
controlled	O
with	O
complication:	O
___	O
controlled	O
on	O
admission,	O
history	O
of	O
vascular	O
disease.	O
Last	O
admission	O
patient	O
had	O
hypoglycemic	O
episodes	O
on	O
half-dose	O
Glyburide,	O
maintained	O
on	O
insulin	O
sliding	O
scale	O
with	O
plan	O
to	O
restart	O
when	O
taking	O
reliable	O
POs	O
and	O
tolerated.	O
While	O
here	O
pt	O
was	O
started	O
on	O
lose	O
dose	O
glipizide	O
(better	O
for	O
renal	O
failure)	O
and	O
sliding	O
scale	O
was	O
continued.	O
.	O
#.	O
Anemia,	O
iron	O
deficiency:	O
Iron	O
studies	O
___	O
___	O
consistent	O
with	O
iron	O
deficiency.	O
Patient	O
has	O
known	O
history	O
of	O
guaiac	O
+	O
stools,	O
prior	O
GI	B-Upper_gastrointestinal_haemorrhage
bleeding	B-Upper_gastrointestinal_haemorrhage
with	O
anticoagulation	O
without	O
definite	O
source	O
ever	O
identified	O
per	O
OMR	O
notes.	O
He	O
did	O
have	O
guaiac	O
positive	O
stools	O
here.	O
Continued	O
iron	O
supplements.	O
Hct	O
stable	O
at	O
27.2	O
prior	O
to	O
discharge.	O
.	O
#	O
Tremors:	O
Noted	O
over	O
past	O
several	O
days	O
prior	O
to	O
admission,	O
at	O
rest	O
and	O
with	O
movement.	O
Noted	O
diffusely.	O
Likely	O
was	O
just	O
related	O
to	O
infection	O
as	O
these	O
resolved	O
with	O
antibiotics.	O
TSH	O
was	O
normal.	O
.	O
#.	O
Chronic	O
Kidney	O
Disease,	O
Stage	O
III:	O
Renal	O
function	O
at	O
baseline	O
or	O
lower	O
than	O
baseline	O
___	O
2.0).	O
Cr	O
1.5	O
prior	O
to	O
discharge,	O
but	O
can	O
allow	O
creatinine	O
to	O
rise	O
closer	O
to	O
2.0	O
with	O
titration	O
of	O
CHF	O
meds	O
as	O
per	O
above.	O
.	O
#.	O
Aspiration:	O
Passed	O
S+S	O
eval	O
last	O
admission,	O
cleared	O
for	O
regular	O
consistency.	O
He	O
was	O
maintained	O
on	O
aspiration	O
precautions.	O
.	O
#	O
Atrial	O
Fibrillation	O
s/p	O
PCM:	O
Pt	O
not	O
anticoagulated	O
due	O
history	O
of	O
GI	B-Upper_gastrointestinal_haemorrhage
bleed.	B-Upper_gastrointestinal_haemorrhage
Continued	O
ASA.	O
.	O
#.	O
Coagulopathy:	O
INR	O
1.5	O
on	O
admission,	O
likely	O
nutritional.	O
He	O
received	O
several	O
doses	O
of	O
Vitamin	O
K	O
here,	O
bringing	O
INR	O
down	O
to	O
1.3.	O
.	O
#	O
CODE	O
STATUS:	O
Pt	O
expresses	O
inclination	O
towards	O
DNR/DNI	O
status.	O
Family	O
had	O
convinced	O
pt	O
to	O
be	O
FULL	O
CODE	O
on	O
admission,	O
but	O
given	O
pts	O
poor	O
overall	O
prognosis	O
(per	O
cardiology,	O
pt	O
could	O
live	O
another	O
year	O
or	O
two,	O
but	O
he	O
will	O
likely	O
experience	O
frequent	O
hospitalizations	O
___	O
the	O
near	O
future)	O
it	O
was	O
discussed	O
with	O
family	O
today	O
that	O
DNR/DNI	O
would	O
be	O
more	O
appropriate	O
and	O
more	O
consistent	O
with	O
pts	O
wishes.	O
The	O
son	O
agreed	O
and	O
will	O
speak	O
to	O
pt	O
about	O
this.	O
Medications	O
on	O
Admission:	O
Medications:	O
Per	O
accompanying	O
med	O
list	O
from	O
___	O
Ciprofloxacin	O
5500mg	O
bid	O
(started	O
___	O
Metronidazole	O
500mg	O
tid	O
(___)	O
Aspirin	O
325mg	O
daily	O
Carvedilol	O
3.125mg	O
bid	O
Digoxin	O
0.0625mg	O
every	O
other	O
day	O
Torsemide	O
40mg	O
daily,	O
hold	O
for	O
SBP	O
<	O
100	O
Lisinopril	O
2.5mg	O
once	O
daily,	O
hold	O
for	O
SBP	O
<	O
100	O
Ascorbic	O
Acid	O
___	O
bid	O
Ferrous	O
Sulfate	O
325mg	O
daily	O
Folic	O
Acid	O
1mg	O
daily	O
Gabapentin	O
100mg	O
tid	O
Insulin	O
sliding	O
Scale	O
Lactobacillus	O
once	O
daily	O
Tylenol	O
___	O
q	O
4hr	O
PRN	O
Bisacodyl	O
10mg	O
PR	O
PRN	O
Colace	O
250mg	O
daily	O
PRN	O
Senna	O
once	O
daily	O
PRN	O
Discharge	O
Medications:	O
1.	O
Lisinopril	O
5	O
mg	O
Tablet	O
Sig:	O
Two	O
(2)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
2.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
3.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
Q6H	O
(every	O
6	O
hours)	O
as	O
needed.	O
4.	O
Heparin	O
(Porcine)	O
5,000	O
unit/mL	O
Solution	O
Sig:	O
5000	O
(5000)	O
units	O
Injection	O
TID	O
(3	O
times	O
a	O
day).	O
5.	O
Digoxin	O
125	O
mcg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
6.	O
Aspirin	O
325	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
7.	O
Ferrous	O
Sulfate	O
325	O
mg	O
(65	O
mg	O
Iron)	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
8.	O
Folic	O
Acid	O
1	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
9.	O
Gabapentin	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
TID	O
(3	O
times	O
a	O
day).	O
10.	O
Carvedilol	O
3.125	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
11.	O
Senna	O
8.6	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day)	O
as	O
needed	O
for	O
constipation.	B-Constipation
12.	O
Vancomycin	O
1,000	O
mg	O
Recon	O
Soln	O
Sig:	O
One	O
(1)	O
gram	O
Intravenous	O
q48	O
hr:	O
until	O
___.	O
13.	O
Ceftazidime	O
2	O
gram	O
Recon	O
Soln	O
Sig:	O
Two	O
(2)	O
gram	O
Intravenous	O
once	O
a	O
day:	O
Until	O
___.	O
14.	O
Glipizide	O
2.5	O
mg	O
Tab,Sust	O
Rel	O
Osmotic	O
Push	O
24hr	O
Sig:	O
One	O
(1)	O
Tab,Sust	O
Rel	O
Osmotic	O
Push	O
24hr	O
PO	O
DAILY	O
(Daily).	O
15.	O
Torsemide	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
twice	O
a	O
day.	O
16.	O
Insulin	O
Lispro	O
100	O
unit/mL	O
Solution	O
Sig:	O
One	O
(1)	O
unit	O
Subcutaneous	O
ASDIR	O
(AS	O
DIRECTED):	O
per	O
sliding	O
scale:	O
For	O
___	O
of:	O
150-200	O
give	O
2	O
U,	O
201-250	O
give	O
4U,	O
251-300	O
give	O
6	O
U,	O
301-350	O
give	O
8	O
U,	O
351-400	O
give	O
10	O
U.	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Pleural	O
effusion	O
Health	O
care	O
associated	O
pneumonia	B-Lower_respiratory_tract_infection
Chronic	O
systolic	O
CHF	O
Left	O
lower	O
lobe	O
lung	O
collapse	O
Hypotension	O
Discharge	O
Condition:	O
stable	O
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
with	O
fluid	O
___	O
your	O
left	O
lung.	O
You	O
underwent	O
a	O
procedure	O
called	O
a	O
thoracentesis	O
___	O
which	O
fluid	O
was	O
removed	O
from	O
your	O
lung.	O
You	O
also	O
were	O
diagnosed	O
with	O
continued	O
pneumonia.	B-Lower_respiratory_tract_infection
You	O
were	O
treated	O
with	O
antibiotics	O
while	O
here.	O
___	O
addition,	O
you	O
had	O
collapse	O
of	O
your	O
left	O
lower	O
lung.	O
You	O
underwent	O
bronchoscopy	O
and	O
this	O
showed	O
inflammation	O
___	O
your	O
left	O
lung,	O
likely	O
consistent	O
with	O
pneumonia/infection.	B-Lower_respiratory_tract_infection
.	O
Weigh	O
yourself	O
everyday.	O
If	O
you	O
gain	O
more	O
than	O
3	O
lbs	O
you	O
need	O
to	O
call	O
your	O
cardiologist,	O
Dr.	O
___.	O
Your	O
weight	O
here	O
was	O
145	O
lbs.	O
.	O
Call	O
your	O
doctor	O
or	O
return	O
to	O
the	O
ER	O
for	O
shortness	O
of	O
breath,	O
fevers,	O
chest	O
pain,	O
or	O
any	O
other	O
concerning	O
symptoms.	O
Followup	O
Instructions:	O
___	O

